Literature DB >> 9361174

Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

G Addolorato1, E Capristo, G F Stefanini, G Gasbarrini.   

Abstract

BACKGROUND: The etiology of inflammatory bowel disease is unclear, and the role played by anxiety and depression is highly controversial. Anxiety and depression in patients with inflammatory bowel disease could be secondary to disabling symptoms, but the interaction between physical morbidity and psychologic illness in these subjects has not been sufficiently investigated. Patients with inflammatory bowel disease are nevertheless frequently undernourished, but there are no studies on the association between anxiety and depression and malnutrition. This study was designed to characterize anxiety and depression in subjects affected by inflammatory bowel disease and to establish the influence of physical morbidity and/or nutritional status on psychologic disorders.
METHODS: Seventy-nine consecutive patients, 43 with Crohn's disease (CD) and 36 with ulcerative colitis (UC), were enrolled in the study. An index of the disease activity and physical morbidity was obtained by the simplified Crohn's Disease Activity Index and Truelove-Witts criteria and using the Clinical Rating Scale. Thirty-six healthy volunteers were studied as controls. All the subjects were given the State and Trait Anxiety Inventory (STAI) test and the Zung self-rating Depression Scale.
RESULTS: The percentage of subjects with state anxiety was significantly higher in the CD (P < 0.001) and UC (P < 0.001) groups than in control subjects. There was no significant difference in trait anxiety among groups. The percentage of subjects with depression was significantly higher in the CD (P < 0.05) and UC (P < 0.05) groups than in control subjects. State anxiety and depression were significantly associated with physical morbidity and correlated with malnutrition in CD and UC patients.
CONCLUSION: Anxiety and depression in patients with inflammatory bowel disease could be reactive to the disabling symptoms and to malnutrition. As measured with the STAI, personality trait of anxiety does not seem to play an important role in inflammatory bowel disease.

Entities:  

Mesh:

Year:  1997        PMID: 9361174     DOI: 10.3109/00365529709011218

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  65 in total

Review 1.  Dietary management of IBD--insights and advice.

Authors:  Emma P Halmos; Peter R Gibson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 3.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

4.  Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.

Authors:  Giovanni Maconi; Daniele Gridavilla; Caterina Viganò; Roberta Sciurti; Anil K Asthana; Federica Furfaro; Federica Re; Sandro Ardizzone; Gabriella Ba
Journal:  Int J Colorectal Dis       Date:  2014-07-02       Impact factor: 2.571

5.  Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.

Authors:  Sara Horst; Andrew Chao; Michael Rosen; Anne Nohl; Caroline Duley; Julianne H Wagnon; Dawn B Beaulieu; Warren Taylor; Lawrence Gaines; David A Schwartz
Journal:  Dig Dis Sci       Date:  2014-10-02       Impact factor: 3.199

6.  Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.

Authors:  Neeraj Narula; Mohan Cooray; Rebecca Anglin; Zack Muqtadir; Alisha Narula; John K Marshall
Journal:  Dig Dis Sci       Date:  2016-12-14       Impact factor: 3.199

7.  Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.

Authors:  Antonina A Mikocka-Walus
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

Review 8.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

9.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 10.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.